Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0040822 (tremor)
 18,428 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A double-blind crossover study was performed to evaluate the bronchodilating effect of different single doses of procaterol (less than 0.5 micrograms/kg, 1.5 micrograms/kg, and placebo) orally administered. Sixteen asthmatic children, age 6-12 years, participated in the trial. Pulmonary function, heart rate, blood pressure, and tremor were evaluated at 30, 60, 90, and 120 min and then hourly for 8 hours after administration. All three doses were therapeutically effective. The 1.5 micrograms/kg dose produced a more sustained bronchodilatation effect, but was also associated with an increase in the incidence of tremors. The 0.5 micrograms/kg dosage may, however, be a good starting dose because it assures a reasonable risk/benefit ratio.
 ...
PMID:Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages. 213 15

In anaesthetized or decerebrate cats, motor axons in lumbosacral ventral roots or hindlimb muscle nerves were stimulated with random trains of brief electrical pulses, and Renshaw cell spike sequences were recorded. Spectral analysis was used to determine the range of linear operation of Renshaw cells, via coherence computations, and to calculate their frequency-dependent gains and phases. The analysis showed that the dynamic behaviour of Renshaw cells was different for different strengths of their synaptic input from motor axons and for different mean stimulus rates. In general, the changes in dynamics associated with variation of these two input parameters followed a common trend. This can be related to the average response of Renshaw cells per stimulus, as assessed by peri-stimulus time histograms. For axons having a strong excitatory effect on a Renshaw cell (as judged from the size of early peri-stimulus time histogram peaks), and for low mean stimulus rates (10-23 pulses per second), the linear range of signal transmission (assessed by coherence computation) was usually very broad (from zero sometimes up to over 100 Hz, but mostly up to 50-100 Hz). Following an initial elevation in the range 2-15 Hz, the gain showed first a rapid decrease with frequency, down to a value which at 30-50 Hz could be a tenth of the gain at lower frequencies (2-15 Hz); it then continued to decline slowly. Otherwise the linear range was narrower and/or the coherence was generally lower; the gain was lower and showed little decline with frequency. The phase curves of Renshaw cells generally showed a low-frequency phase lead (up to roughly 10 Hz) and an increasing phase lag thereabove that was generated in part by the conduction delay. The results show that Renshaw cells can follow, particularly sensitively, inputs in a frequency range encompassing the steady firing rates of many alpha-motoneurons. This range of high gain also covers that of a component of physiological tremor (ca. 6-12 Hz), a basic mechanism of which is probably related to unfused contractions of newly recruited motor units firing in this range. It can therefore be expected that recurrent inhibition via Renshaw cells is especially powerful in this physiologically important range of alpha-motoneuron firing.
 ...
PMID:Frequency response of spinal Renshaw cells activated by stochastic motor axon stimulation. 343 82

Fifty-eight patients, 36 with essential tremor (ET) and 22 with Parkinson's disease (PD), received deep brain stimulation (DBS) in the thalamic ventral intermediate (Vim) nucleus. The mean follow-up was 17 months for ET and 21 months for PD patients. Stimulation parameters were adjusted as needed, at various intervals after surgery. Results were assessed using routine clinical evaluation and established outcome scales. All patients needed incremental increase in stimulation parameters at various intervals during the first 6-12 months after surgery. The mean voltage 1 week postoperatively was 1. 45 V in PD patients, and 1.37 V in ET patients. Twelve months later, the figures were 2.14 V in PD and 2.25 V in ET patients. At 1 year, the Essential Tremor Rating Scale (ETRS) improved from 54 to 28 (p < 0.0001). The motor part of the Unified Parkinson's Disease Rating Scale (UPDRS) improved from 37 to 26 (p < 0.01). Tremor items of the UPDRS improved more markedly (p < 0.0001). One week postoperatively 90% of PD, and 89% of ET patients were tremor free. One year later, 70% of PD and 60% of ET patients remained mostly tremor free. Upon switching off stimulation, there was a clear tendency for tremor rebound (p = 0.07) in the PD group, requiring continuous 24-hour stimulation in some patients. Permanent non-adjustable ataxia was induced by stimulation in 2 PD patients.
 ...
PMID:Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. 1085 80

Ventrolateral (VL) thalamotomy produced a marked reduction of oscillations related to the supraspinal components of Parkinson's disease tremor (4-7 Hz) and physiological tremor (8-12 Hz). Finger tremor was examined in nine patients undergoing unilateral VL thalamotomy and in nine age-matched controls. In comparison to the preoperative state, the relative percentage of power within the 7.6-12.5 Hz band did not increase after the surgical procedure. Furthermore, the amount of absolute power within the 7.6-12.5 Hz band was much lower for post-surgical patients in comparison to matched controls when periods of tremor having equal amplitudes were compared. These results suggest that VL thalamotomy interrupts a common circuit involved in the supraspinal component of both physiological and pathological tremors. We provide evidence that the thalamus may be involved in circuits generating physiological tremor in humans.
 ...
PMID:Evidence that ventrolateral thalamotomy may eliminate the supraspinal component of both pathological and physiological tremors. 1085 46

The aim of this study was to evaluate the safety of long-term treatment with tiagabine. We reviewed the case report forms of patients with refractory partial epilepsy who took tiagabine for longer than 6 months in two long-term studies. We classified all adverse events based on severity and persistence, and recorded the dose at onset of each adverse event. We then divided patients into those treated for 6-12 months, 12-24 months and > 24 months. We compared the adverse event profile and change in seizure frequency among the three groups. Forty-two patients took tiagabine for longer than 6 months. The mean duration of treatment was 22.6 months. The mean monthly seizure frequency was 12.7 at baseline and 8.1 at study termination (36% decrease). The most common adverse events were: tiredness (56%), headache (46%), dizziness (44%), visual symptoms (blurring, difficulty focusing, diplopia) (39%), altered mentation (32%), and tremor (31%). The adverse event profile was comparable among the three groups. Seizure frequency was significantly more improved in the > 24 months group. Long-term treatment with tiagabine is well tolerated. The most important predictor of long-term therapy with tiagabine was the degree of seizure improvement.
 ...
PMID:Safety of long-term treatment with tiagabine. 1098 2

This study compared the efficacy and safety of the selective serotonin reuptake inhibitor sertraline with that of the tricyclic antidepressant clomipramine in patients with severe depression, as defined by a baseline 17-item Hamilton Depression Rating Scale (HAM-D) of at least 25. The study included 166 outpatients, randomized to double-blind treatment with sertraline (50-200 mg) or clomipramine (50-150 mg) for 8 weeks. The efficacy of both treatments was similar, 74% of patients in the sertraline group and 71% of clomipramine patients being classified as responders at the end-point, as defined by a Clinical Global Impression-Improvement (CGI-I) score of 1 or 2. Mean HAM-D scores fell from 29.8 at baseline to 12.3 at endpoint in the sertraline group, and from 29.6-12.7 in the clomipramine group. There were more withdrawals due to adverse events in the clomipramine group than in the sertraline group (17% versus 12%). Dry mouth, tremor, dizziness and constipation were all substantially more common in the clomipramine group, whereas diarrhoea/loose stools was more common in the sertraline group. Overall, sertraline was as effective as clomipramine in this group of severely depressed outpatients, and showed better tolerability.
 ...
PMID:A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression. 1099 28

Whole scalp magnetoencephalography (MEG) signals were recorded in 10 healthy subjects simultaneously with the surface electromyogram (EMG) of the contralateral forearm extensor muscles during isometric contraction and phasic movement of the wrist. In eight subjects, coherence and time domain analyses demonstrated correspondence between the MEG signal, originating near or in the hand region of the motor cortex, and the 6-12 Hz EMG recorded during isometric postural contractions. In contrast, we found little evidence for correspondence between the contralateral EMG and the MEG recorded over the Rolandic region during phasic movements. We conclude that the sensorimotor cortex is differentially involved in physiological force and action tremor at the wrist.
 ...
PMID:Involvement of the sensorimotor cortex in physiological force and action tremor. 1143 26

The study aimed to compare olfactory function in idiopathic Parkinson's disease (IPD) and nonidiopathic Parkinson's syndrome (PS). At their first visit 50 PS patients (age 38-80 years) received testing for odor threshold, olfactory discrimination and identification. All patients underwent extensive neurological diagnostics including PET scans. Patients were followed up for 6-12 months. Most of IPD patients were functionally anosmic (n=19), the remaining IPD patients had severe/moderate hyposmia (n=18). PS patients diagnosed with multiple system atrophy had less severe olfactory deficits (7 hyposmia, 1 normosmia). With the exception of 1 hyposmic patient, other PS patients had no olfactory deficits (progressive supranuclear palsy, corticobasal degeneration, psychogenic PS, essential tremor). This study added to previous findings: (1) there was no major difference betwesen olfactory function in IPD subtypes; (2) all olfactory tests differentiated IPD from nonIPD. These data suggest that olfactory probes improve the diagnostic armamentarium in IPD.
 ...
PMID:Olfactory function in Parkinsonian syndromes. 1238 7

We report a cohort of 21 patients (12 females and nine males), with a mean age of 42.4 years, who developed tremor after receiving fluoxetine at a mean dose of 25.7 mg per day. The mean latency period for tremor appearance was 54.3 days. Severity was found to be mild. In all patients, tremor was postural, with P<0.0005, compared to patients with rest tremor and P<0.05 compared to action/intention-tremor patients. The frequency range was 6-12 Hz/s. After fluoxetine was discontinued, tremor disappeared in 10 patients after a mean latency period of 35.5 days. In the remaining 11 patients, tremor persisted up to the end of the observation period (a mean of 449 days). We believe that this tremor phenomenon is due to the involvement of the red nucleus and the inferior olivary nucleus through their projections to the thalamus and the spinal cord.
 ...
PMID:Fluoxetine-induced tremor: clinical features in 21 patients. 1517 61

We have previously shown that the application of anaesthesia to periodontal mechanoreceptors (PMRs) dramatically reduces the 6-12 Hz physiological tremor (PT) in the human mandible during constant isometric contractions where visual feedback is provided. This current study shows that during a ramp contraction where force is slowly increased, the amplitude of mandibular PT is almost five times smaller on average than when the same force ramp is performed in reverse, i.e. force is slowly decreased. This smaller tremor is associated with a higher mean firing rate of motor units (MUs) as measured by the sub-30 Hz peak in the multi-unit power spectrum. The decrease in the amplitude of PT following PMR anaesthetisation is associated in some instances with a similar increase in the overall firing rate; however this change does not match the diminution of tremor. The authors postulate that the decrease in mandibular PT during increasing force ramps may be due to a change in the mean firing rate of the MUs. The change in tremor seen during PMR anaesthetisation may in part be due to a similar mechanism; however other factors must also contribute to this.
 ...
PMID:Mandibular physiological tremor is reduced by increasing-force ramp contractions and periodontal anaesthesia. 1768 34


1 2 Next >>